Clinical Trial Update: FMT for MS Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for fecal microbiota transplantation in multiple sclerosis patients; status information is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Multiple Sclerosis | Phase 2 | Status: UNKNOWN